Abstract-Metabolic pathways in cells convert external food and resources into useful cell components and energy. In many cases the cell employs product inhibition to regulate and control these pathways. We investigate the performance of such regulation and control on certain autocatalytic pathways. Specifically, we examine how well the pathways can maintain the desired output concentrations in the presence of disturbances, such as perturbations in resources, enzyme concentrations and product demand. Using control theoretic tools, we show the effects of the pathway size, the reversibility of the intermediate reactions and the coupling of pathways through the consumption of intermediate metabolites on performance. In addition, we establish some necessary conditions on the existence of fixed points and their stability for such pathways.
x 1 x 2 x n y Fig. 1 . The autocatalytic network is composed of a chain of reversible reactions (black arrows) that convert one metabolite (black circles) to another. The pathway requires the consumption of the final product (blue triangles) to convert its input into the first metabolite. Additionally, the product of the pathway inhibits (dotted red line) the enzyme that catalyzes the autocatalytic reaction and the pathway product and intermediate metabolites are consumed by other processes in the cell (dotted blue arrows).
Nonlinear stability and region of attraction properties for such autocatalytic pathways (with application to glycolysis pathway) are the subject of [2] , [3] , focusing on the case in which the intermediate reactions are not reversible and there is no intermediate metabolite consumption. For general biochemical networks, stability and the existence of steady states have been the subject of study for many decades. Results regarding the number of steady states and convergence properties around steady states for rather general networks with mass-action kinetics are established in [4] , [5] , [6] . Local and global convergence properties have been established for many network topologies such as monotone dynamical systems [7] , [8] and cyclic interconnection networks [9] , [10] , [11] , [12] .
Here, we are primarily interested on the performance of autocatalytic metabolic pathways near their biological operating point. In particular, we study how the pathway can best maintain the desired output concentration in the presence of disturbances such as perturbations in resource availability, product demand and enzyme concentrations using feedback inhibition. Using tools from linear systems theory, our previous work on a simple two-state pathway (figure 2a) showed that autocatalysis can aggravate controller performance [13] . We have shown that this reduced model captures the essence of glycolysis pathway and glycolytic oscillations, but it is sensitive to parameter perturbations and exhibits a very rich dynamic behavior. Perturbations in the parameters can make the system undergo a variety of bifurcations, such as saddle-node, Hopf and homoclinic bifurcations [2] , [14] . This can cause the system to oscillate (limit cycles) or even crash, implying that none of the theorems or existing theory that rule out such behavior are applicable. Since this level of parameter sensitivity of the dynamics is not immediately obvious from the structure of the reduced model or the underlying biology, it is important to explore more realistic pathway models and examine how perturbations in the structure of the chemical reactions in the pathway model effect dynamics and performance. In this paper, we investigate how the size of the pathway, the reversibility of the intermediate reactions and the coupling of pathways through the consumption of intermediate metabolites effect their performance (figure 2). In the case when there is coupling to other pathways via intermediate metabolite consumption, we establish some necessary conditions on the existence of fixed points. The rest of the paper is organized as follows: We introduce the pathway model in the next section, followed by a discussion of control and performance in section II-A. Next we consider the different topologies separately, by looking at large pathways in section III, pathways with reversible reactions in section IV and pathways with intermediate metabolite consumption in section V. The more general pathways are discussed in section VI.
II. MODEL DESCRIPTION
Consider the autocatalytic metabolic pathway with multiple intermediate metabolite reactions (figure 1)
Here, u is some precursor and source of energy for the pathway with no dynamics associated, y denotes the product of the pathway, x i are intermediate metabolites, ϕ is a null state, a is the number of y molecules that are invested in the pathway, and a + b is the number of y molecules produced. A f B denotes a chemical reaction that converts chemical species A to species B at rate f and A B denotes a reversible reaction (i.e., both the reaction that converts A to B and the one that converts B to A are present). The corresponding ordinary differential equations arė
. . .
and g y are continuous, monotone, increasing functions that vanish at 0. These assumptions are consistent with large classes of chemical kinetics models such as mass-action and Michaelis-Menten. The rate f (y) of the autocatalytic reaction captures the negative feedback of the output (y) via the inhibition of the catalyzing enzyme of the first reaction. We choose f (y) = V y q 1+γy h that is consistent with biological intuition and experimental data (in the case of the glycolysis pathway [15] , [16] ). In this parameterization V > 0 depends on the concentration of the input (u), q > 0 captures the strength of autocatalysis and γ > 0 and h > 0 capture the strength of inhibition (negative feedback). Note that f is not monotone and captures the coupling between the autocatalysis and inhibition. For the rest of the paper, we take a = b = 1 and note that the generalization of the results for a > 0 and b > 0 is straightforward.
A. Feedback Mechanism, Sensitivity Function, Zeros
If a nonzero fixed point (x,ȳ) (0, 0) of (1) exists, then without loss of generality we setȳ = 1 (and assume so for the rest of the paper). Defineĥ := γ γ+1 h, and
The dynamics of (1) near the fixed point are given by the following linear system
for x ∈ R n , y ∈ R and where B :
and for all i, m i := k i + r i + η i , r 1 := 0 and δ y = k y + 2r y . Notice that equation (2) can be viewed as the closed-loop dynamics ofξ
using a proportional (negative) feedback controller of gain h (i.e., ν = −ĥζ). Biologically, the gainĥ captures the strength of the inhibition of the autocatalytic reaction by the pathway product (in the case of glycolysis, it captures the strength of inhibition of the catalyzing enzyme PFK by ATP [2] ). Figure 3 shows the feedback structure of system (3), where
In this paper, we explore the performance of the controller on the different network topologies shown in figure 2 by investigation of the sensitivity function S, given by S(s) =
1+ĥP (s)
. S captures the ability of the system to reject many relevant disturbances, such as perturbations δ in the pathway product consumption rate (i.e., perturbations of the RHS of equation (2) by [0, . . . , 0, 1] T δ) or in the consumption rate of other metabolites. In the topologies we investigate, the plants P have right half-plane (RHP) zeros which introduce theoretical limits on performance captured by a special form of the Bode's integral formula [13] ,
where z is a RHP zero and M = ln | Comparison of performance in these different topologies can be tricky, since these topologies imply fundamental changes in the "plant" and the number and locations of the fixed points of the (nonlinear) closed loop system (1). The assumption that the (operating) equilibrium concentration of the pathway output y is fixed and normalized to 1 for all topologies makes such comparisons appropriate, since it directly addresses the question of which topology is easier to control, i.e., in which pathway topology the controller can best maintain the desired concentration of the output y of the pathway in the presence of disturbances.
III. LONGER PATHWAYS
In this section we investigate the topology of figure 2c, i.e., a pathway of size n + 1 with no reversible reactions and no consumption of any of the intermediate metabolites (in equation (1),
The coefficients of the numerator of P (s), given by
, do not have the same sign. This implies that the polynomial n 1 (s) is not Hurwitz stable and therefore P (s) has at least one RHP zero and equation (4) holds for the n-D pathway.
Let us look at the case where
the system is stable for gains q − 1 <ĥ <ĥ d (n) [3] , [11] . This implies that, in general, as the pathway size increases, the upper bound on stable feedback gainsĥ decreases. The zeros of P (s) are given by s = k 2 This fact, coupled with the conservation law given by (4), implies that as the number of intermediate reactions grows the price paid for performance at small frequencies increases substantially ( figure 4 right) . So the increase in the intermediate metabolite reactions has two main consequences.
• The price for good performance at low frequencies increases as the magnitude of the RHP zero gets smaller.
• The upper bound on the feedback gains gets smaller, so the range of stable gains gets smaller. For example look at the DC gain (steady state error) of a n-D system with q = 2, k y = V 0 = 1. From (5) we get P (0) = 1 and the DC gain S(0) = 1 1+ĥ
. It is clear that the DC gain improves as the gain increases, however the (top-left) Plot of log |S| for the same feedback h = 3.8, shows that the higher dimension systems pay a higher price at higher frequencies for similar performance at low frequencies (top-right) Closed-loop system step response shows that the same gainĥ = 3.8 yields the same steady state error for all 3 systems. However higher dimensional systems have poorer transient response. (bottom-left) Lower dimensional systems have access to higher gains, which means that they can get better performance at low frequencies. The plot of log |S| forĥ = 5.5, 4, 3.8 for two-state, three-state and four-state systems respectively, illustrates the difference in performance at low frequencies, and the price paid at higher frequencies (comparable for all 3 systems). (bottom-right) Closed-loop system step response shows that access to higher gains for the low dimension systems (ĥ 2D = 5.5,ĥ 3D = 4,ĥ 4D = 3.8) achieves smaller steady state error and better transient response as well.
maximumĥ that still stabilizes the system gets smaller as n increases. Therefore lower dimensional systems can achieve better DC gain (steady state error). Figure 5 illustrates the consequences of increased pathway size on performance by looking at log |S| and the step response for comparable twostate, three-state and four-state systems. In general, long pathways in the cell can be biochemically unavoidable or even necessary (such as the intermediate metabolites are crucial to other processes in the cell). The cell uses means such as employing metabolite channeling [17] instead of free diffusion, to counteract the adverse effect of large pathway size.
IV. REVERSIBLE REACTIONS
We investigate the topology of figure 2b, i.e., a pathway of size 2 with one reversible intermediate reaction, but no consumption of the intermediate metabolite (in equation (1) 
The system is stable for gains q − 1 V0 k y <ĥ < q + 1 V0 (k 1 + k y + 2r y ) and so the presence of the reversible reactions increases the range of stable gainsĥ. This suggests that the reversible reactions make the pathway easier to control. There is still a RHP zero at s = k 1 since P (s) = −V 0 s−k1
, where p J0 is the characteristic polynomial of J 0 . This implies that equation (4) holds for this system. However, because the range of the stable gains is larger for higher reversible reaction (RR) rates, the same feedback gain is more "robust". This suggests that systems with higher RR rates have better performance (i.e., smaller peak in the log |S|, and smaller oscillations in the step response, ( figure  6 top-left, top-right) . It also means that higher gains can (bottom) Models with higher reversible reaction rates allow for higher stabilizing gains. Usingĥ = 7.5, 5.5, 3.5 respectively, we obtain better performance at low frequencies (bottom-left) and better steady state error (bottom-right) for the systems with higher RR rates.
be used for systems with high RR rates to obtain better performance at low frequencies and better steady state error without a meaningful increase in performance losses at high frequencies and qualitatively similar oscillations in the step response, as shown in figure 6 bottom-left and bottom-right. The improvement in performance by having reversible reactions is to be expected, since the reversible reactions act as local feedback loops. For example the pathway studied in this section, is (locally) equivalent to a two state pathway with no reversible reaction, but where the product y controls both the autocatalytic and the intermediate reaction. 
and it can be shown that it is open-loop (ĥ = 0) stable when η 1 is close enough to k 1 . Notice that η 1 cannot be larger than k 1 , since for δ := η 1 − k 1 > 0 and δ < k y η1+k1 η1+k1+ky , the system is not stabilizable.
Under the above conditions, the consumption of the intermediate increases the range of stable gainsĥ. Similar to the RR case, this suggests that the consumption of the intermediate metabolite might make the pathway easier to control. However, the plant has a RHP zero at s
. This implies that as η 1 increases the magnitude of the RHP zero gets smaller, thus imposing harder constraints on performance. There appears to be is compared. Using the same feedback gainĥ = 3 , the systems with less consumption of intermediates have better performance, which corresponds to a smaller peak in log |S| plot, and less oscillations in the step response.
another tradeoff, and it is not immediately clear whether or not the consumption of intermediates helps the performance of the system. Define m(
. This results in a system of the form;
These equations show that consumption of intermediates has the same effect as reducing the net product of the pathway. For example, if g x (x) = kx and d x (x) = βkx, then α = β β−1 and this pathway is equivalent to a pathway with g x (x) = (1 + β)kx that produces (2 − α) molecules of y for each molecule y invested. As Figure 7 shows, larger β leads to worse tradeoffs on achievable performance and more oscillations for the same steady state error.
VI. GENERAL PATHWAYS
We now consider the general autocatalytic metabolic pathway given by equation (1) (figure 1) .
A. Existence of the Fixed Point
Let us first consider l y = 0, l i = 0, ∀i, i.e., no reversible intermediate reactions. Assume that the fixed point (x,ȳ) (0, 0) exists, then
This implies that the fixed point (x,ȳ) (0, 0) exists only if
where
. We can think of p i (x i ) as the "rate" that a molecule x i will continue to the next step of the pathway (i.e., will be converted into x i+1 ), and 1
gi(xi)+di(xi) the rate that it will be used by another pathway. Then the rate that a molecule x 1 (produced by the first reaction through the investment of 1 molecule of y) will ultimately be converted into 2 molecules of y and not be used by other pathways is given by 
So for a pathway of size 10, α has to be less than 0.072, i.e., only a small percentage of the intermediate metabolites can be consumed at each step.
In the general case, where the intermediate reactions are reversible, we can get a similar condition to (6) by considering the "net flow"
B. Stability of the Fixed Point
For the cases when a nonzero fixed point (x, 1) (0, 0) of (1) exists, we establish bounds on gainsĥ that guarantee stability of the pathway for arbitrary size (n) and arbitrary values of intermediate reaction rates
Proposition 1: (a) Letĥ r := q + We now show we can construct an unstable system for anŷ h =ĥ r + , > 0. In equation (2), let r y = 0, and for all i, r i = 0,
k . The real part of the eigenvalue λ 0 , is given by
. This implies that for n large enough, the system (2) is unstable since γ(n) > 1 and therefore (λ 0 ) > 0.
VII. CONCLUSIONS
Output feedback regulation of the pathway shown in figure  1 , can counteract the destabilizing effects of the positive feedback generated by autocatalysis, thus guaranteeing the local stability of the operating fixed point. However the The existence of a RHP zero z is at the core of many of the limitations imposed on performance for these pathways, captured by a special form of the Bode Sensitivity Integral. These limitations are aggravated by smaller magnitude RHP zeros. As shown in [13] , high concentration of catalyzing enzymes leads to an increase in the rates of the intermediate reactions (k i ), which makes the pathway more stable (i.e., there is a larger range of stable gains available) and increases the magnitude of z (i.e., "softens" the hard limits on performance).
Increased pathway size has the opposite effect of increasing the enzyme concentrations on pathway performance. An increase in the size of the chain of enzymatically catalyzed intermediate reactions in the autocatalytic pathways causes two adverse effects on performance: tradeoffs on performance limits are exacerbated (as z becomes smaller) and the range of available stable gains is reduced, which makes the operating gains less robust and reduces the achievable performance objectives.
Consumption of intermediates in autocatalytic metabolic pathways results in less resources available to convert to the product of the pathway, which effectively reduces the net product of the pathway (i.e., how much product y is produced per unit y invested in the autocatalytic step). This effective reduction in net output production makes the pathway harder to control because it corresponds with the RHP zero getting smaller, and thus aggravating the tradeoffs on performance limits. Additionally, these pathways must enforce a positive return in the energy investment, i.e., for each unit of y invested at the beginning, it must produce at least that much y produced by the end of the pathway. Therefore, the loss of the intermediates to the other pathways must be only a fraction of the available resources, otherwise excessive consumption of these intermediates causes the pathway to crash.
On the other hand, the presence of reversible reactions makes the autocatalytic pathways easier to control, as they function as "release valves" by making higher stable gains available, thus providing more robustness and better achievable performance objectives. Figure 8 shows a summary of the role of concentration of catalyzing enzymes, pathway size, consumption of intermediate metabolites, and reversible reactions in determining the stability and performance of the pathway.
